Rhygaze Competitors: 10 Similar Biotech

Rhygaze — investors and similar companies (53)

Companies comparable to Rhygaze in Biotech, headquartered in Basel, Switzerland, ranked by how much of Rhygaze's verified investor base they share. 150 of the companies below have at least one backer in common with Rhygaze.

Overlap is computed from disclosed round records rather than from sector labels, so a company appears here because the same firms wrote cheques into both — the signal a founder benchmarking comparables or an investor mapping a sector actually wants. Each entry links to that company's own funding record and syndicate breakdown.

• Verified backers on record: 5
• Total disclosed funding: $97M
• Latest tracked round: Series A (2024-12-05)
• Sector: Biotech
• Headquarters: Basel, Switzerland

• GV
• ARCH Venture Partners
• F-Prime Capital
• BioGeneration Ventures
• Novartis Venture Fund
• Genesis Global — shares GV
• OnDeck — shares GV
• TScan Therapeutics — shares GV +1
• Aerami Therapeutics — shares Novartis Venture Fund
• You.com — shares GV
• SonderMind — shares F-Prime Capital
• Chroma Medicine — shares GV
• Recursive — shares GV
• OMass Therapeutics — shares GV
• Redpanda Data — shares GV
• Cockroach Labs — shares GV
• Incorta — shares GV
• Dewpoint Therapeutics — shares ARCH Venture Partners
• Treeline Biosciences — shares Arch Venture Partners +1
• Soufflé Therapeutics — shares ARCH Venture Partners
• LifeMine Therapeutics — shares GV +1
• SambaNova Systems — shares GV
• Tenvie Therapeutics — shares ARCH Venture Partners +1
• Odyssey — shares GV
• Resilience — shares ARCH Venture Partners
• Paradigm — shares ARCH Venture Partners
• Headway — shares GV
• Atlas Data Storage — shares ARCH Venture Partners
• Affinia Therapeutics — shares F-Prime Capital
• Aspen Neuroscience — shares ARCH Venture Partners
• Anokion — shares Novartis Venture Fund
• Tome Biosciences — shares Arch Venture Partners +1
• Vividion Therapeutics — shares ARCH Venture Partners
• Midi Health — shares GV
• Verve Therapeutics — shares GV
• dbt Labs — shares GV
• Chiasma — shares ARCH Venture Partners
• Semisic — shares GV
• Turo — shares GV
• Capstan Therapeutics — shares Novartis Venture Fund
• Science 37 — shares GV
• Merus — shares Novartis Venture Fund
• Codiak Biosciences — shares ARCH Venture Partners
• Intercom — shares GV
• Neumora Therapeutics — shares ARCH Venture Partners +1
• Accent Therapeutics — shares GV
• HiberCell — shares ARCH Venture Partners
• Medbanks — shares F-Prime Capital
• Protego Biopharma — shares Novartis Venture Fund
• Nanosys — shares ARCH Venture Partners
• Mirador Therapeutics — shares ARCH Venture Partners
• UpStream Care — shares ARCH Venture Partners
• Brii Biosciences — shares ARCH Venture Partners

Rhygaze funding profile · All research reports